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The aim of this work is the production and characterisation of sol–gel coatings for protection and bioactivation
of metals used as standard surgical implant materials, such as stainless steel 316 L (ASTM F138), Co based
alloys (ASTM F75) and titanium alloy Ti-6Al-4V (ASTM F67). These films should both prevent degradation
of the substrates by wear or corrosion, and bioactivate the material for inducing the formation of a
hydroxyapatite (HA) rich layer onto the material surface, thereby permitting a natural bonding to living tissues.
Formation of HA layers can be observed on performing in vitro tests by soaking the material in simulated body
solutions. The work describes the development of coatings containing bioactive glass and glass-ceramic particles
in hybrid methyl-triethoxysilane (MTES) and tetraethylorthosilicate (TEOS) acidic sol, applied by dip-coating
to surgical alloys, AISI 316 L, ASTM F75 and ASTM 67, with the aim of accomplishing both high corrosion
resistance of the metal in the body environment and adhesion of the implant to the surrounding tissue.
The performance of the coated metal was evaluated in vitro by electrochemical techniques including
potentiodynamic polarisation curves and electrochemical impedance spectroscopy, to follow the formation of
hydroxyapatite on the surface, as well as the in vitro release of ions by plasma atomic emission spectroscopy
(ICP-MS) after up to one year of immersion. In vivo behaviour was evaluated by subcutaneous tests and
endomedullar implantation in Hokaido rats to study possible rejection reactions and natural bonding to
living tissue.
1. Introduction
Biomedical prosthetic devices are used in the human body to
carry out the functions no longer performed by the original
parts. Metals are used in the human body mainly for
orthopaedic purposes and their degradation by wear and/or
corrosion must be negligible. Standard surgical implant
materials include stainless steel 316 L (ASTM F138), Co
based alloys (mainly ASTM F75, and F799) and titanium
alloys; where Ti-6Al-4V (ASTM F67 and F136) are the most
employed. The use of these alloys for orthopaedic appliances
requires the formation of a passive film to prevent oxidation.
These films consist of metal oxides which form spontaneously
on the metallic surface to limit the transport of metal ions
across the metal oxide–solution interface. These films should
not only be non-porous and fully cover the metal surface but
must also remain on the surface under mechanical stresses. In
addition the surface should allow repassivation in case of film
removal or damage.1
Cobalt based alloys are widely used for fabrication of diverse
surgical devices due to their good corrosion and wear resistance
as well as their good biocompatibility. The main corrosion
products, CoO and Cr2O3, may react with water to form
Co(OH) and Cr(OH)3.
2 Cell culture has demonstrated that
chromium species can stimulate osseous resorption and
necrosis of periprosthetic tissue.3
Titanium alloys are employed for orthopaedic implants due
to their excellent combination of biocompatibility, corrosion
resistance and mechanical properties. However, toxicity of
alloying elements and a high elastic modulus compared to bone
have been reported as possible disadvantages.4 Although
titanium has excellent corrosion resistance, if any of the
alloying elements are released into the tissue by corrosion or
wear, tissue reaction may vary, ranging from a mild response,
such as the discoloration of surrounding tissue, to a severe one
causing pain and even loosening of the device.5
AISI 316L stainless steel is widely used in applications where
the implant is temporary, although it is also employed for
permanent implants. However, it tends to localised corrosion
releasing significant quantities of iron ions to the neighbouring
tissues with the consequent risk of local tumours and mechani-
cal failure of the implant.6,7
For permanent prosthesis and especially for joint replace-
ment, it would be desirable to avoid cementing of prostheses by
promoting natural bonding to hard and soft tissues.8–11
Uncemented prosthetic components with porous surfaces are
increasingly used in total joint replacement surgery for young
and active patients.12 However, for this kind of patient, who
may have a postoperative life expectancy of more than thirty
years, the carcinogenic potential of metal elements used in total
hip arthoplasty components is a great concern, particularly
because of the high exposed surface of porous devices inserted
without cement.1
One way to minimise the release of corrosion products from
the implant to the surrounding tissue is to apply protective
coatings. Such films should also be functional with bioactive
material for inducing the formation of a semi-crystalline
hydroxyapatite (HA) rich layer onto the material surface,
generating a natural bond to living tissues. HA can be
detected after in vitro tests performed by soaking the material
in simulated body solutions (SBF), Hank’s balanced salt
solution (HBSS), and other solutions that simulate bodyD
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fluids.13–15 This behaviour is considered an indication of in vivo
bioactivity.16–18
The sol–gel method has been proposed as a suitable pro-
cedure to produce protective19–21 and bioactive22,23 coatings.
The advantages and technological significance of these sol–gel
coatings over those produced by other methods have been
widely demonstrated.24–26 One of the most attractive charac-
teristics of the sol–gel method is that through the use of
different precursors, thermal treatments, or addition of
particles in the sol, functional coatings can be obtained. Sol–
gel processing has been employed to some extent for preparing
bioactive glasses and gels.27–32 The range of bioactivity in the
CaO–SiO2–P2O5 system is larger for bulk materials prepared
by sol–gel than for the same glass compositions obtained by
melting.31 Some porous SiO2 gels also show in vitro induction
of HA deposition.33 However, crack-free coatings for composi-
tions showing bulk bioactivity (16% CaO, 4% P2O5, 80%
SiO2)
30 prepared by using calcium methoxide, triethylpho-
sphate and TEOS as sol precursors,21 showed no in vitro
formation of HA after 1 month of immersion in SBF.
Differences between sol–gel bulk and film behaviour can be
attributed to the higher density of coatings,34 which limits their
reactivity.
Galliano and co-workers demonstrated that inorganic and
hybrid SiO2 coatings obtained from tetraethylorthosilicate
(TEOS) and/or methyltriethoxysilane (MTES) as SiO2 pre-
cursors using acid catalysts improve the corrosion behaviour of
AISI 316L stainless steel in biological environments.21 Coat-
ings were applied as mono and multilayers by a multistep
method. XPS analysis of inorganic and hybrid SiO2 coatings on
steel substrates showed that using TEOS as the only precursor
results in some extent of Fe diffusion, but the hybrid coatings
prepared from MTES/TEOS limited the diffusion of iron to
surface during thermal treatment, with much lower iron
contents than those reported for bioactivity inhibition.35
This work describes the development of sol–gel coatings
containing bioactive glass and glass-ceramic particles in hybrid
silica matrices, applied by dip-coating to surgical alloys
including ASTM F75, ASTM F 67 and AISI 316 L. The
deposition of these coatings has two main objectives: the
reduction of corrosion of the substrates in the body and
stabilization of the implant (without the use of cement),
allowing the growth of new osseous tissue around the insert.
The performance of the coated metals was evaluated in vitro by
following the formation of hydroxyapatite on the surface using
electrochemical techniques. In addition, in vitro ions release
was measured by mass plasma atomic emission spectroscopy
(ICP-MS) after long periods of immersion. In vivo behaviour
was evaluated by subcutaneous and endomedullar implanta-
tion in Hokaido rats.
2. Experimental
2.1. Synthesis of silica sol and suspensions
Tetraethylorthosilicate (TEOS) and methyltriethoxysilane
(MTES), both from ABCR, were selected as SiO2 precursors
for the hybrid sol (sol HS), prepared in alcoholic media using
HNO3 and acetic acid as catalysts. A molar relationship
MTES/TEOS of 60/40 was employed, fixing R~ 2, where R~
H2O/(MTES 1 TEOS). The final concentration of SiO2 was
200 g l21.
The bioactive glass belongs to the CaO–SiO2–P2O5 system
with 57.44 CaO, 35.42 SiO2 and 7.15 P2O5 in molar percent-
ages. Silica sand with low Fe2O3 content, CO3Ca (Panreac) and
POH3 (Merck) were used as raw materials. The glass was
obtained by melting the batch at 1600 uC for 2.5 hours then
quenching in water at room temperature.35,23 Bioactive glass-
ceramic particles were obtained from this glass employing a
heat treatment for 2 hours at 1050 uC to induce crystallization
of hydroxyapatite and wollastonite. All the bioactive particles
were milled in a planetary mill (Fritsch Pulverisette, Germany),
with agate jar and balls at 1500 rpm for a maximum period of
1 h. After milling, the powders were sieved, using Tyler sieves
numbers 270 (54 mm), 325 (43 mm), 400 (37 mm) and 600
(25 mm). Different fractions were selected to analyse the influ-
ence of particle size on the coating behaviour. The particle size
distribution and the specific surface area were determined by
laser diffraction and N2-adsorption BET.
Stable suspensions were obtained by adding 5 and 10 wt% of
particles to the hybrid silica sol. Three different particle sizes
were used for studying the kinetics of reaction in vivo and
in vitro. Suspensions with small bioactive particles of diameter
around 5 mm were prepared by using phosphate ester (Emphos
PS21, Whitco Chem, USA) as processing additive and further
addition of citric acid to obtain a suitable pH. Larger particles
of glass (w # 39mm) and glass-ceramic (w # 17mm) were also
employed for preparing stable suspensions by using tetrapropyl
ammonium hydroxide (TPAH, Aldrich) in a concentration of
50 wt% with respect to solids.
The stability of the suspensions was evaluated by measuring
the viscosity as a function of time. Rheological measurements
were performed using a rotational rheometer (Haake RS50,
Germany) with a double-cone and plate-measuring system.
2.2. Substrates and coatings
Three alloys were studied: CrCoMo alloy (ASTM F75), Ti 6Al
4V (ASTM F68) and stainless steel AISI 316L. Plane sheets of
cast CrCoMo alloys (F75 alloy, Zimmer Inc.) of around 2 cm2
were cut and polished with emery paper and alumina (0.3 mm)
until a mirror finish was achieved. Wires of 1.4 mm diameter of
CrCoMo alloy (Zimmer Inc.) were also made by polishing at
one end in order to obtain a needle-like shape to improve the
deposition of the sol and increase fixation in the in vivo studies.
Samples were cleaned in an ultrasonic bath and dipped in
isopropyl alcohol prior to coating. Plates (25mm6 50mm) and
surgical nails (w~ 1.5 mm) of as-received AISI 316L stainless
steel (average roughness, Ra ¢ 2) were also employed.
Cleaning was performed with the following schedule: 5 min
in alkaline bath (demineralised water : P3 Emalan 5668 : P3
Emalan 0469~ 1000 : 50 : 5) at 60 uC, 1 min in demineralised
water at room temperature and 1 min in demineralised water at
60 uC. Titanium plates of 35 6 50 mm were used as-received
and cleaned in the same manner.
The metallic substrates were coated by dipping to obtain
mono and double-layer coatings. Single coats were obtained
from the glass and glass-ceramic/hybrid sol suspensions, as well
as from the pure hybrid silica sol, and thermally treated at
450 uC for 30 min in air. The double-layer coatings were pre-
pared in two steps, with a first inner film obtained from the
hybrid SiO2 sol, heat-treated with the same schedule. The
second layer, deposited from the suspensions with bioactive
particles, were thermally treated again at 450 uC for 30 min.
Coatings were also applied onto glass-slides for thickness mea-
surements, performed with a mechanical profilometer Talystep
(Taylor–Hobson). Mono and two-layer coatings were con-
trolled by optical microscopy (Olympus BX41).
The concentration of the particles in the coatings was
calculated by obtaining a digital image of each coating in an
optical microscope (Olympus BX-41) using a video system
consisting of a CCD sensor connected to an acquisition card
IMAQ-PCI-1408 (National Instruments, TX, USA) in a PC
IBM, controlled by software developed in LabView 5.1.
(National Instruments, TX, USA) and Matlab 5.3 (Math-
Works, Inc., MA, USA). The software enhances the contrast of
the image to clearly distinguish the particles from the matrix
and afterwards calculates the concentration of each phase
present.
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2.3. In vitro assays
In vitro assays were conducted either in simulated body fluid
(SBF)13 at 37 uC, pH 7.3¡ 0.1, prepared with bidistilled water
grade I (Millipore) or in commercial Hank’s balanced salt
solution (HBSS, SIGMA). Electrochemical experiments were
performed using electrochemical units (Solartron 1280B and
Gamry CSM 100). A saturated calomel electrode (SCE)
(Radiometer) was used as reference electrode and a platinum
wire was used as secondary electrode. Impedance experiments
(EIS) were conducted at the corrosion potential (Ecorr) with an
amplitude of 0.005 V r.m.s; frequency was swept from 100 kHz
to 0.01 Hz. Potentiodynamic polarisation curves were collected
applying a cathodic potential step of 300 mV with respect to the
Ecorr; the anodic sweep at 0.002 V s
21 starts from this value up
to 1.2 V versus SCE where the reverse scan initiates.
In vitro bioactivity tests were performed on coated samples
by immersion in HBSS at 37 uC during different periods of
time, with a ratio between the sample area and the fluid volume
of 0,4 cm ml21. Deposition of apatite, the bone mineral phase,
onto the surface of the coatings, considered as a preliminary
signal of bioactivity,13 was followed by specular reflection
infrared spectroscopy (FTIR), X-ray diffraction (XRD) and
scanning electron microscopy (SEM).
Ion release in simulated body fluids has been studied with
ICP-MS for long-term tests of up to one year. Samples were
immersed in narrow glass tubes containing the minimum SBF
solution to totally cover the sample surface and maximise the
concentration of released ion. The average volume of SBF in
contact with each sample was 19 ml. Solutions were analysed,
on soaking from one month to one year depending on the
substrate together with a reference SBF bath (without sample).
Tests were performed at 5 and 37 uC to confirm the stability of
the solution.
2.4. In vivo assays
In vivo experiments were conducted with Hokaido rats. Sub-
cutaneous tests were performed with the aim of testing the
possible rejection reactions. Three animals were implanted with
square (15 mm 6 15 mm) coated and uncoated plates in the
muscle dorsal area. Implantation was performed under sterile
conditions and plates were situated under the skin, contacting
the muscle fascia. After one month, the animals were sacrificed
and the implanted material with the surrounding tissues was
extracted.
For endomedullar studies, coated and uncoated wires were
sterilised by dry heat in an electric oven (Hogner) over a period
of one hour at 160 uC. CrCoMo wires of w~ 1.4 mm, 3–4 cm in
length were placed in the tibia cortical bone of five animals. The
implants were inserted while the rats where sedated under 1 ml
Innovan (Janssen Lab., droperidol and fentanyl citrate)
anaesthetic. The animals were placed in a supine position
and painted with a colourless antiseptic. The implantation site
was exposed through the superior part of the internal face of
the tibia. A region of around 5 mm diameter was scraped in the
tibia plateau to prepare the burring area. A hand drill with a
1.5 mm bur was used at low rotation rate (120¡ 10 rpm). The
implantation site was irrigated with physiological saline
solution for cooling and cleaning purposes during the drilling
procedure and before the implant was inserted. The coated and
uncoated wires were located by a press fit technique in both
tibias of the rat, extending into the medullar canal. The wound
was closed with conventional suturing. The rats were sacrificed
with an overdose of intraperitoneal Innovan after 53 days and
X-rayed before retrieving the tibia. The retrieved sections were
examined for the presence of bone/sol–gel coating interface
and bone/alloy interface. Each rat had one uncovered wire in
one tibia bone and a coated wire in the other tibia. The material
was placed in neutral formol. Osseous tissue was decalcified
and multiple cuts at various levels were made to improve
fixation. The material was cut on a microtome, stained with
haematoxylin and eosin and observed by an optical transmis-
sion microscope (Leica DLM); photographs were taken and
analysed by a viewer (Leica DC Viewer).
3. Results and discussion
3.1. Characterisation of sols, suspensions and coatings
Stable glass/hybrid sol suspensions with non-agglomerated
powders, necessary for obtaining homogeneous and crack-free
layers, were prepared from differently sized particles. The best
results for small glass particles (wm ~ 5 mm, Se ~ 3 m
2 g21)
were obtained by using 0.1 wt% (referred to dry solids) of
phosphate ester, adjusting the suspension pH to 3.8 by adding
citric acid. The suspensions were stable for several days. Some
sedimentation was observed when stored without agitation, but
was easily re-dispersed on stirring. Viscosity showed neither
significant variation with glass content, nor with storage time
(up to one week), maintaining a value between 2–3 mPa s in all
cases. The phosphate ester was first added to promote its
adsorption onto the particle surfaces, acting as an anionic
surfactant.36 This affects the sol by raising the pH, so that a
further acid addition is needed to prevent destabilization of
the sol.35
In the case of larger particles (w ~ 40 mm, Se ~ 0.3 m
2 g21
for glass, and w ~ 16 mm, Se ~ 0.8 m
2 g21 for glass-ceramic
powders) stability was obtained by adding TPAH, which raises
the suspension viscosity up to 7 mPa s; the stability is
maintained for 8 hours. TPAH acts as a cationic surfactant
which is adsorbed on the particles; it also increases the pH to
6–7, so that the solution is far from the isoelectric point and
electrostatic repulsion among the particles is favoured.37
The coatings obtained from the suspensions containing glass
and glass-ceramic particles are composed of a glassy matrix
with a secondary phase of particles with a concentration of
10–15 vol%, depending on the withdrawal and evaporation
rates. The embedded particles appear separated showing a
uniform distribution throughout the coatings, which demon-
strates the stability and homogeneity of the precursor suspen-
sions during the process. Fig. 1 shows a typical homogeneous
and defect-free distribution of small glass particles (a) and
medium size glass-ceramic powders (b) in the hybrid silica
matrix. The critical thickness is between 1.5 and 3 mm depend-
ing on the particle size; in both types of coatings, some defects
and cracks appear for thicker films. The inner hybrid silica
coating was 1 mm thick, and the double layer thickness was
between 2.5 and 3 mm.
3.2. In vitro electrochemical assays
Electrochemical tests showed that the presence of coatings
always improves the corrosion resistance of all the metallic
substrates. Fig. 2a shows typical polarisation curves for as-
received and mono and double-layer coated F75 alloy in
neutral SBF solution. It is observed that the alloy remains
passive over a broad potential range before the breakdown
potential (Er) is reached. The protection potential was found to
be 0.11 V positive to the open circuit potential. Thus, once the
failure is initiated, re-passivation would be difficult since the
protection potential is quite close to the corrosion potential.
Degradation would then proceed, causing emission of undesir-
able corrosion products to the environment. The general shape
of the polarisation curve for the bare alloy is similar to that of
pure chromium. It has been previously demonstrated that the
passive film is composed of chromium and/or cobalt species
such as Co(OH)2 and Cr2O3, which is partially converted to
Cr(OH)3.
2 The deposition of the hybrid coating decreases the
passive current density for all the studied coatings. Although
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there are no changes in the breakdown potential, the protection
potential shifts 0.5 V positive to the corrosion potential,
suggesting that this system is more likely to repassivate when
the film is damaged. The differences found in the current
density of coatings containing 5 and 10 wt% of powder may be
due to particle agglomeration caused by the higher concentra-
tion. This may induce the appearance of microcracks during
heating and/or cooling after densification. After 30 days of
immersion in SBF, the passivation current density of the coated
samples is still lower than that of coated samples, indicating
that the sol–gel film deposited on the surface is preventing
corrosion.38 Although the current density presented for the
coated samples showed an increase with potential, it was
always lower than that of the uncoated samples. Therefore,
around Ecorr, the corresponding density current is more that
two orders of magnitude lower for coated samples than for the
uncoated samples.
As cobalt-base alloys are susceptible to crevice attack, coated
pieces were tested in SBF acid solution (pH 0.7) in order to
simulate the acidic media and the high chloride concentrations
that develop when a crevice is formed. This attack could take
place when partial scaling of the coating occurs. In acidic
solution, the surface of the bare alloy is passive with low
density currents until the breakdown potential is reached, as
observed in Fig. 2b). The potential protection for the bare alloy
in acidic SBF is around 0.1 V and seems not to improve for
coated samples. Nevertheless, both the bare and the coated
alloy showed low passive current densities that remained very
stable within a broad potential range (1.3 and 1.1 V for the
coated and uncoated alloy respectively). Thus, it is likely that
these systems present good ability for re-passivation in acidic
solution and an acceptable localised corrosion resistance.
Fig. 3 shows potentiodynamic polarisation curves for Ti-
6Al-4V with single and double layers with 10 wt% of glass
particles compared with the uncoated metal. The anodic
reverse scan corresponding to the alloy Ti-6Al-4V occurs at
lower current densities due to the growth of a protective oxide
layer during the anodic sweep. It can be observed that the
coating drastically reduces ipass, and it is probable that the sol–
gel coating is also blocking active sites, reducing the effective
electroactive area. Moreover, no change in the potential
breakdown Er was observed. This potential can be defined as
that where a continuous increase in the anodic current under
potentiodynamic control implies localised corrosion, either
through pitting or crevice corrosion or transpassivation. This
behaviour, together with the fact that the Ecorr values are the
same as that of the uncoated substrate, suggests there is open
porosity, which leaves the alloy in contact with the solution.
Thus, exposed substrate oxidises as the uncoated Ti-6Al-4V
does, but over a much smaller area; consequently, the current
density is also lower. Impedance measurements also indicate
that the coating is porous.
Fig. 4 shows the evolution of the impedance spectra of a
monolayer with 10 wt% of glass particles as a function of time.
The spectra indicate the rapid disappearance of the coating
Fig. 1 Optical microscopy photographs of double layer coatings:
(a) with small glass particles (medium w # 5mm) and (b) with inter-
mediate glass-ceramic particles (medium w # 16 mm).
Fig. 2 (a) Potentiodynamic polarisation curve for the coated and
uncoated CrCoMo alloy (F75) in neutral SBF solution, v~ 0.002 V s21.
(a) Double-layer coating with 5 wt% glass-ceramic; (b) Single layer with
5 wt% glass-ceramic; (c) Double-layer coating with 10 wt% glass-
ceramic; (d) Single layer with 10 wt% glass-ceramic; (e) uncoated
CrCoMo alloy. (b) Potentiodynamic polarisation curve for the coated
and uncoated CrCoMo alloy in acidic SBF solution, v~ 0.002 V s21.
(a) Double-layer coating with 10 wt% glass-ceramic; (b) Single layer
with 10 wt% glass-ceramic; (c) uncoated CrCoMo alloy.
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response with a decrease of /Z/. After 6 months of immersion in
HBSS, the behaviour of coated and uncoated substrates is
similar as a consequence of particle dissolution. The corrosion
resistance of titanium alloys results from the formation of a
very stable and highly adherent oxide film onto the metal
surface. This film is spontaneously formed when exposed to
oxygen (even in traces) and it is able to reform in the event of
damage. In most aqueous environments, TiO2 forms, but it
may also be a mixture of different oxides such as Ti2O3 and
TiO.39
The third substrate employed was AISI 316L. While Ti and
Cr alloys are widely used in permanent implants, AISI 316L is
mostly employed in temporary devices. An extended electro-
chemical study has been conducted on this alloy with protective
bioactive coatings, in order to follow its corrosion behaviour in
long term applications in SBF, with the aim of lengthening its
lifetime to permanent orthopaedic implants.
Low sintering temperatures do not sensitise the metallic
substrates as demonstrated by Damborenea,40 preserving the
mechanical properties and avoiding the intergranular corrosion
of the alloy.
Both single hybrid silica and double layered coatings with
10 wt% glass and glass-ceramic bioactive particles were depo-
sited and studied. Fig. 5 shows the potentiodynamic curves for
a pure silica coat and a double-layer coating compared with the
uncoated stainless steel. Both coatings reduce the passive
current density (ipass) by more than three orders of magnitude
with respect to the substrate; Er reaches values as high as
1.25 V/SCE, providing a wide passivity range. The potential
breakdown (Er) is higher than the pitting potential (Epitt) for
uncoated steel; a higher pitting resistance is therefore expected
for coated samples. Er values are related to the oxygen evolu-
tion in the metal/coating interface, from electrolyte that may be
accessed through pores or diffusion through the film, which
leads to blistering of the coating. The very low ipass indicates a
small defect size and low density of defects in the coating, and
thus an exposed metallic surface area three orders of magnitude
lower than that of the uncoated metal.
Glass-ceramic coatings applied onto hybrid silica show
anomalous behaviour with time. After 10 days of immersion,
the samples have lower current densities than after 24 hours,
possibly due to the blocking of pores with HA as a result of the
reaction between glass-ceramic particles with SBF (not shown).
This behaviour suggests that dissolution products are impeding
the electrochemical process at the pores or defects of the
coating, acting as a protective layer against corrosion and ion
diffusion. In addition, these products promote further deposi-
tion of a semi-crystalline HA rich layer that can stimulate the
primary stabilization of the implant.
The evolution of coatings with time was followed by EIS.
Fig. 6 presents the behaviour of a double-layer coating with
10 wt% of glass particles, with respect to bare substrate. Two
time constants become apparent after only three days of
immersion in HBSS. The simultaneous appearance of a
breakdown frequency, fbreak, and its shifting to higher fre-
quencies with immersion time indicate a progressive increase of
the defective area. The external coat containing glass particles
induces a higher defect density in the coating in comparison to
hybrid silica. However, the response in the low frequency
region indicates a diffusion controlled mechanism, and hence
substrate attack remains negligible. Fig. 7 compares the EIS
spectra of bare and coated AISI 316L after six months of
immersion. The metal presents a pure capacitive response while
both coated samples continue to show a diffusion controlled
Fig. 4 EIS spectra of Ti-6Al-4V alloy with monolayer coating with
10 wt% glass particles. Evolution with immersion time: (&) 1 day, (#)
1 week, (+) 1 month, (+) 3 months, (Y) 6 months.
Fig. 5 Potentiodynamic polarisation curves for (a) hybrid silica and
(b) double layer with 10 wt% glass particles compared with (c) bare
AISI 316L stainless steel.
Fig. 3 Potentiodynamic polarisation curves for the coated and
uncoated Ti-6Al-4V alloy in neutral SBF solution, v ~ 0.002 V s21.
(a) Double-layer coating with 10 wt% glass; (b) Double-layer coating
with 10 wt% glass-ceramic; (c) Single layer with 10 wt% glass;
(d) Uncoated Ti-6Al-4V alloy.
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mechanism, indicating that the barrier effect of the films
remains unaltered for such long times.
3.3. In vitro assays
For an artificial material, the most essential requirement for
bonding to a living tissue is the natural generation of bone-like
apatite on its surface in the physiological environment. An
initial evaluation of the bone-bonding ability of a material may
be obtained by in vitro experiments in which surface formation
of apatite is examined in a simulated body fluid.13 Deposition
of HA was followed by FTIR, a method sensitive to the
vibration modes which are characteristic for molecular con-
stituent groups, permitting the detection of HA and its growth
on the material surface.41–43 FTIR and XRD were used to
follow the growth of apatite with time and as a function of the
type and concentration of particles, the particle size and the
thickness of the coating. The deposition of HA was similar for
glass and glass-ceramic particles of the same concentration.
The deposition rate is faster for higher concentrations, lasting
from 7–10 days for coatings with 5 wt% glass to less than 3 days
for coatings containing 10 wt% glass or glass-ceramic particles.
The deposition kinetics also depends on particle size, with
faster rates observed for smaller powders. No relationship with
the coating thickness could be determined.
Fig. 8 shows a micrograph of a double layer with 10 wt%
glass particles onto AISI 316L after one week of immersion.
Deposition and crystal growth were followed by the increment
of the corresponding FTIR signals. As XRD pattern obtained
after 7 days of immersion in HBSS showed peaks correspond-
ing to crystalline apatite; the low intensity is probably due to
the expected low crystallinity of the HA deposit. Similar results
were obtained for the other studied alloys.
3.4. Ion release
One of the concerns about surgery alloys is the potential
toxicity of the metals ions that can be released in the body
environment. Sol–gel coatings were formulated to serve not
only for the primary stabilisation of the tissue but also as a
barrier to release of ions.
ICP and ICP-MS were carried out for the different alloys.
The Co-base alloy showed a concentration of Co ions more
than one order of magnitude lower after 30 days of immersion
when coated with double-layer coatings with bioactive glass-
ceramic particles, indicating the barrier effect of these coatings
against diffusion. Cr diffusion is lower still, being under the
detection limit of the equipment.
ICP-MS has been used for characterising as-received and
coated AISI 316L samples for immersion times of up to one
year. This technique permits concentrations in the level of
ng mL21 to be detected. For Cr, Ni and Mo ions the detection
limit is about 1 ng cm22. From tests performed at 5 and 37 uC,
no Mo ions were detected after 12 months of immersion. Fig. 9
shows the behaviour of released Ni as a function of time for
bare and coated steel. All the coatings seem to act as barriers
against diffusion, with the best effects observed for hybrid silica
and double-layer coatings with glass particles. Similar beha-
viour is observed for Cr diffusion. After longer immersion
times, the behaviour of the hybrid silica and double-layer
coatings is similar, confirming the results obtained from
electrochemical measurements.35 The single glass particles
containing coatings have higher ion diffusion. This is likely
resulting from partial dissolution of the particles that creates
flaws and pores, allowing the fluid to come in contact with the
substrate. In contrast, a coat of hybrid silica, alone or as first
coat in double-layer films, shows a prolonged protecting
barrier effect.
Using the 57Fe isotope of iron, free from isobaric interferences,
results in a higher detection limit of around 10 ng cm22. Under
these conditions, only the pure hybrid silica coatings can be
considered as an effective barrier against diffusion. The glass
and glass-ceramic bioactive particles, melted using low Fe
containing sand, are partially dissolved when immersed in SBF,
masking the detected Fe values. Further work is in process to
study this problem.
The diffusion results obtained by ICP-MS suggest that sol–
gel coatings act as diffusion barriers reducing the release of ions
and preventing the possibility of biotoxicity.
3.5. In vivo assays
Preliminary short-time subcutaneous in vivo tests were carried
out to determine the influence of implants during the first stages
of healing. The main objective of these assays was to detect
possible rejection reactions of living tissues with AISI 316L
Fig. 6 EIS spectra of AISI 316L coated with a double layer coating
with 10%wt glass particles. Evolution with time: (&) 1 h, (#) 1 day,
(,) 3 days, (+) 2 weeks, (Y) 1 month, (&) 3 months, (6) 6 months.
Fig. 7 EIS spectra of AISI 316L coated with: (a) hybrid single silica
coating; (b) double-layer coating with 10 wt% glass particles, compared
with bare material (c).
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samples coated with hybrid silica and with bioactive glass
containing films, compared with the bare substrates. After one
month of implantation, it was noticed that although both
coated samples promote the formation of a fibrous capsule
around the implant, this capsule is much thinner for the sample
with the particle containing coating. No evidence of corrosion
and better tissue–implant interaction in the samples coated
with HS and with particle containing films with respect to the
uncoated steel were observed; the possibility of a negative
response from soft tissues may, therefore, be excluded.35
The interaction between osseous tissue and sol–gel coating
was studied by the press fit technique. All five animals used in
the in vivo endomedular study were ambulatory for 24 h post-
operation and showed predisposition for feeding and healing of
wounds in both legs. None of the implants became clinically
infected and no signs of infection or displacement of any of the
samples were observed during the study.
Fig. 10 shows an X-ray of one of the animals after 53 days of
implantation. Fig. 11 presents a micrograph of tissue that was
in contact with CrCoMo alloy covered by a double sol–gel
coating with 10 wt% glass-ceramic during the same implant
period (2006 magnification). Well conserved muscular tissue
in the peripheries and spicules of osseous tissue were observed
for all the samples; the tissue did not, therefore, appear to be
affected by the metallic implant. A new lamellar histionic
structure with plexiform features made of collagen tissue (non-
mineralised) and vascular development is observed. As this
new tissue showed extensive vascularity, it is possible that the
tissue is growing with an osteoid structure. In contrast, all the
uncoated wires showed poor vascularity in the new tissue
(Fig. 12). It is, thus, reasonable to assume that this tissue
structure is less effective for enhancement of bone growth.38
These results are encouraging with respect to the potential of
sol–gel coatings on improving the osseo-integration of the
Fig. 8 (a) Hydroxyapatite (HA) deposited onto a double-layer coating with 10 wt% glass particles after 1 week of immersion in HBSS, at 37 uC.
(Bar~ 20 mm); (b) FTIR spectra of the same coating after different soaking times in HBSS; bands corresponding to apatite are indicated; (c) XRD
patterns of the deposit formed on the double layer coating before (b) and after (a) 1 week of immersion. HA and Fe peaks are indicated.
Fig. 9 Ni ions release as a function of time for AISI 316L: (&)
uncoated, (#) hybrid coating and (,) mono and (+) double-layer
coatings containing 10 wt% glass.
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metallic implants. In vivo assays are also in progress for
titanium and stainless steel alloys. Bigger animals (rabbits)
and longer implantation times (up to six months) are being
employed in order to evaluate bone regeneration and the
implant/bone adhesion around coated samples.
4. Conclusions
Continuous and defect-free hybrid sol–gel coatings were
obtained on surgery alloys. The incorporation of bioactive
glass or glass-ceramic particles on the surface promoted
bioactivity.
Electrochemical characterisation of samples coated with
mono and double-layer coatings showed a dramatic reduction
of the passive current densities compared with the bare alloys.
The coatings improved the protection potential of the base
materials in the tested electrolytes. EIS results for immersion
times of up to six months demonstrated the stability of the
coatings and the prevention of electrolyte penetration.
In vitro response was fast and dependent on the concentra-
tion and size of particles but not on the thickness of the coating.
HA deposits of low crystallinity were observed for all the
coated alloys after 3–7 days of immersion in SBF or HBSS.
Sol–gel coatings act as diffusion barriers, strongly impeding
ion release and avoiding biotoxicity.
In vivo tests showed no rejection reactions or inflammatory
response. Endomedullar implants of Co alloys wires coated
with double-layer coatings containing glass-ceramic particles
exhibited newly formed bone with considerable vascular
development, which was not observed in the as-received wires.
The promising results presented in this work suggest that
bioactive particle containing sol–gel coatings are able to
enhance early fixation due to the formation of HA deposits
and neo formed vascular-rich osseous tissue in the tissue–
coating interface. Devices coated with this technology should
provide not only a better corrosion resistance than uncoated
implants, with substantial reduction of the quantity metal ion
release to the body, but also provide a substrate for ingrowth
and bone attachment. They are thus suitable for permanent
implants.
The excellent electrochemical performance of coated AISI
316 L steel in simulated body fluids demonstrates its suitability
for use in permanent orthopaedic appliances, providing a
competitive alternative related to Co and Ti alloys. The mini-
mum ion release and the absence of rejection reactions are
further benefits of this material.
Hybrid pure silica coatings are instead recommended for
temporary devices where superior corrosion resistance and a
barrier to metal ion diffusion are expected. Direct bonding
between the implant and the tissue is thus avoided. The better
tissue–implant interaction of the coated samples with respect to
the uncoated ones with no evidence of rejection is a further
advantage of these coatings.
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